TCTR (Thai Clinical Trials Registry): Registration Process and WHO Primary-Registry Status

The Thai Clinical Trials Registry (TCTR) is Thailand’s national clinical trial registry and one of the primary registries in the World Health Organization’s International Clinical Trials Registry Platform (WHO ICTRP) network. For a sponsor or research administrator running a trial with a Thai site, TCTR registration is the mechanism that satisfies prospective-registration expectations from journals, funders, and Thailand’s own research-transparency policy — a separate track from the Thai FDA/Ethics Committee authorization that permits the trial to actually enroll participants.

What TCTR is and who runs it

TCTR was established in 2009 by a group of Thai academics to give Thailand a national platform for prospective clinical trial registration. It is operated by the Clinical Research Collaboration Network (CRCN), a body under the non-profit Medical Research Foundation, with financial support from the Thailand Center of Excellence for Life Sciences (TCELS). TCTR accepts registrations for any clinical research study conducted in Thailand, not only pharmaceutical trials — it is not limited to drug or device trials the way some national regulatory databases are.

WHO ICTRP primary-registry status

TCTR was recognized as a primary registry in the WHO International Clinical Trials Registry Platform (ICTRP) network in 2013, five years after the registry’s creation. Primary-registry status means TCTR meets the WHO’s own criteria for registry quality and content, and that every trial registered there is automatically discoverable through ICTRP’s global search portal — sponsors do not need to separately register the same trial with WHO. TCTR sits alongside a small set of other national and regional primary registries research administrators are likely to already work with, including ChiCTR (China) and CTRI (India). Data registered in TCTR is periodically converted into WHO’s standard XML export format and fed into the ICTRP portal, which is how a Thailand-only registration becomes globally searchable without a duplicate submission.

The WHO Trial Registration Data Set TCTR requires

Like every WHO ICTRP primary registry, TCTR requires registrants to complete the WHO Trial Registration Data Set — 20 mandatory items covering the trial’s identifying information, scientific and public titles, countries of recruitment, health condition(s) studied, intervention(s), key inclusion/exclusion criteria, study type and design, target sample size, recruitment status, primary and key secondary outcome measures, and sponsor and contact information. This is the same core dataset clinical trial registration generally is built around across every WHO primary registry — a sponsor who has already assembled this dataset for a ClinicalTrials.gov or ISRCTN submission is largely reusing the same information for TCTR, not starting from scratch.

Registration process

The core steps, drawn from how TCTR and comparable WHO primary registries operate:

1. Create a registrant account on the TCTR platform, providing the principal investigator’s and sponsor’s contact details.
2. Complete the 20-item WHO Trial Registration Data Set for the specific trial, in English (TCTR also supports Thai-language fields for domestic use).
3. Submit for administrative review. A designated TCTR administrator checks the submission against the registry’s completeness and consistency requirements before approving it.
4. Receive a TCTR identifier once approved. TCTR IDs follow the pattern TCTR followed by an eight-digit registration date and a sequence number — for example, TCTR20230429001 — so the ID itself encodes the date the record was approved.
5. Registration record becomes public and is subsequently exported to the WHO ICTRP search portal.
6. Update the record at least every six months, or immediately when recruitment status or key protocol details change — this is a standing obligation, not a one-time filing.

As with every WHO primary registry, TCTR’s stated mission is to encourage prospective registration — before the first participant is enrolled — rather than registering a trial retrospectively after results are already known. Prospective registration is what most journals and the ICMJE’s editorial policy actually require; a trial registered only after enrollment has begun does not satisfy that expectation even though the trial technically appears in the registry.

How TCTR registration relates to Thai FDA and Ethics Committee approval

TCTR registration is a research-transparency and journal/funder-compliance requirement — it is not the same process as, and does not substitute for, the regulatory and ethical authorization a trial needs before it can enroll participants in Thailand. As covered in Thailand’s Thai FDA and Ethics Committee approval pathway, Thai FDA authorization for an investigational drug is gated on Ethics Committee (EC) approval, and both are separate from TCTR registration. In practice, research administrators typically pursue EC review, Thai FDA authorization (where applicable), and TCTR registration in parallel, and complete TCTR registration before the trial’s first participant is recruited — not after Thai FDA sign-off, and not as a substitute for it. A protocol number or Thai FDA reference is commonly cross-referenced in the TCTR record once available, but TCTR itself does not verify regulatory authorization as a precondition for registering a trial.

Practical considerations for research administrators

• Register before enrollment, not after. Retrospective registration is accepted by TCTR mechanically but defeats the transparency purpose the registry — and journals citing WHO-primary-registry status — exist to serve.
• Reuse your WHO dataset across registries. If the trial is also being registered on ClinicalTrials.gov or another WHO primary registry for a multi-country study, the 20-item core dataset transfers directly; only registry-specific administrative fields need to be re-entered.
• Budget for the six-month update cycle. Treat TCTR maintenance as a recurring administrative task tied to the trial’s status changes, not a one-time filing at study start.
• Don’t conflate registration with authorization. A TCTR ID confirms the trial is registered and transparent; it says nothing about whether Thai FDA or EC approval has been granted.

Frequently asked questions

Is TCTR only for pharmaceutical trials?

No. TCTR accepts any clinical research study conducted in Thailand, including observational and non-pharmaceutical interventional studies, not only drug or device trials.

Does a TCTR ID mean the trial has Thai FDA approval?

No. TCTR registration and Thai FDA/Ethics Committee authorization are separate processes. A trial can be registered in TCTR without yet holding Thai FDA authorization, and TCTR does not verify regulatory approval as a condition of registering a record.

How is a TCTR identifier formatted?

TCTR identifiers follow the pattern TCTR plus an eight-digit date and a three-digit sequence number, for example TCTR20230429001.

Is TCTR recognized outside Thailand?

Yes. TCTR has been a WHO ICTRP primary registry since 2013, meaning trials registered there are automatically searchable through WHO’s global ICTRP portal alongside registrations from ClinicalTrials.gov, ISRCTN, ChiCTR, CTRI, ANZCTR, and the other primary registries in the network.